When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Rituximab - Wikipedia

   en.wikipedia.org/wiki/Rituximab

   Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...

3. EPOCH (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/EPOCH_(chemotherapy)

   Day 1 Etoposide: 50 mg/m 2: IV continuous infusion over 24 h: Days 1–4 Prednisolone: 60 mg/m 2: By mouth, twice a day (PO BID) Days 1–5 Oncovin: vincristine: 0.4 mg/m 2: IV continuous infusion over 24 h: Days 1–4 Cyclophosphamide: 750 mg/m 2: IV bolus given over 15 min: Day 5 Hydroxydaunorubicin: doxorubicin: 10 mg/m 2: IV continuous ...

4. Ibritumomab tiuxetan - Wikipedia

   en.wikipedia.org/wiki/Ibritumomab_tiuxetan

   The treatment starts with an infusion of rituximab. This may be followed by an administration of indium-111 labeled ibritumomab tiuxetan ( 111 In replaces the 90 Y component) to allow the distribution of the medication to be imaged on a gamma camera , before the actual therapy is administered.

5. FCM (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/FCM_(chemotherapy)

   In combination with Rituximab, this regimen is called R-FCM or R-FMC, or FCM-R, FMC-R. The [R]-FCM regimen contains Rituximab - anti-CD20 monoclonal antibody that can kill both normal and malignant CD20-bearing B cells; Fludarabine - an antimetabolite; Cyclophosphamide - an alkylating antineoplastic agent from the oxazafosforine group;

6. Rho(D) immune globulin - Wikipedia

   en.wikipedia.org/wiki/Rho(D)_immune_globulin

   Exposure to fetal blood cells that can cause RhD alloimmunization can happen during normal pregnancy and delivery, miscarriage, amniocentesis, cordocentesis, chorionic villus sampling, external cephalic version, or trauma. [3] [8] 92% of women who develop an anti-D during pregnancy do so at or after 28 weeks gestation. [11] [9] [12]

7. CHOP (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/CHOP_(chemotherapy)

   This regimen can also be combined with the monoclonal antibody rituximab if the lymphoma is of B cell origin; this combination is called R-CHOP. In 2002, a randomized controlled trial showed a higher complete response rate for R-CHOP vs CHOP in elderly patients with Diffuse Large-B-Cell Lymphoma (76% vs 63%). [ 4 ]

8. ESHAP - Wikipedia

   en.wikipedia.org/wiki/ESHAP

   In combination with monoclonal antibody Rituximab it is called R-ESHAP or ESHAP-R. [1] R-ESHAP consists of: Rituximab, an anti-CD20-directed monoclonal antibody that kills both normal and malignant B-lymphocytes; Etoposide, an epipodophyllotoxin topoisomerase inhibitor; Solu-Medrol - Methylprednisolone, which is a glucocorticoid that can lyse ...

9. ICE (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/ICE_(chemotherapy)

   In case of CD20-positive B cell lymphoid malignancies the ICE regimen is often combined today with rituximab. This regimen is then called ICE-R or R-ICE or RICE. [R]-ICE regimen consists of: [citation needed] Rituximab - an anti-CD20 monoclonal antibody, which is able to kill both normal and malignant CD20-bearing B cells;